Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Burkitt Lymphoma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Biphenotypic, Acute 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 1Leukemia 1

Interventions

Cytarabine 52Methotrexate 33Cyclophosphamide 33Daunorubicin 29Gene Expression Profiling 27Flow Cytometry 23Vincristine 22Mercaptopurine 19Dexamethasone 19Asparaginase 19Filgrastim 18Microarray Analysis 16Etoposide 16Radiotherapy 15Thioguanine 14Prednisone 14Leucovorin 14Idarubicin 13Polymerase Chain Reaction 12Peripheral Blood Stem Cell Transplantation 12Gemtuzumab 12Doxorubicin 12pegaspargase 10Hydrocortisone 10Calcium Dobesilate 10Busulfan 10Reverse Transcriptase Polymerase Chain Reaction 9Mitoxantrone 9Granulocyte Colony-Stimulating Factor 9Cytogenetic Analysis 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Leukemia × calaspargase pegol × Clear all
NCT01225874 2016-02-23

Biomarkers to Classify Young Patients With Acute Lymphoblastic Leukemia (ALL) and Remission Induction Therapy in Young Patients With B-Precursor ALL

Children's Oncology Group

Phase NA Completed
3,762 enrolled
Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡